Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
A moving target identified in small cell lung tumors

A moving target identified in small cell lung tumors

Researchers develop promising immunotherapy treatment for glioblastoma

Researchers develop promising immunotherapy treatment for glioblastoma

Ivy Center opens new clinical trial to evaluate experimental drug cocktail for glioblastoma

Ivy Center opens new clinical trial to evaluate experimental drug cocktail for glioblastoma

Antimalarial drug shows promise as potential therapy for aggressive brain cancer

Antimalarial drug shows promise as potential therapy for aggressive brain cancer

Genome-wide pattern found in glioblastoma tumors predicts patients' life expectancy

Genome-wide pattern found in glioblastoma tumors predicts patients' life expectancy

Researchers study how brain cancer cells acquire resistance to radiation

Researchers study how brain cancer cells acquire resistance to radiation

Scientists develop new way to deliver molecules that target specific genes within cells

Scientists develop new way to deliver molecules that target specific genes within cells

Combination of schizophrenia drug and radiation shows promise in treating glioblastoma

Combination of schizophrenia drug and radiation shows promise in treating glioblastoma

Cannabidiol could be a useful therapy for difficult-to-treat brain cancer

Cannabidiol could be a useful therapy for difficult-to-treat brain cancer

Combination therapy boosts the immune system's appetite for cancer

Combination therapy boosts the immune system's appetite for cancer

New drug preserves cognitive function in mice after brain irradiation

New drug preserves cognitive function in mice after brain irradiation

Study suggests targeted cancer therapy could help with rare neurologic disease

Study suggests targeted cancer therapy could help with rare neurologic disease

Targeting PI3Kβ alone and with combination therapy in PTEN-deficient tumors

Targeting PI3Kβ alone and with combination therapy in PTEN-deficient tumors

'Natural killer' cells could help stop progression of Parkinson's disease

'Natural killer' cells could help stop progression of Parkinson's disease

New type of adoptive cell therapy could target prostate and pancreatic cancers in humans

New type of adoptive cell therapy could target prostate and pancreatic cancers in humans

Brain imaging may help predict when liquid biopsy will benefit individual glioblastoma patients

Brain imaging may help predict when liquid biopsy will benefit individual glioblastoma patients

Scientists developing a combined vaccine to fight most malignant brain tumor

Scientists developing a combined vaccine to fight most malignant brain tumor

Simple blood test could be used by GPs to aid in earlier brain tumor diagnosis

Simple blood test could be used by GPs to aid in earlier brain tumor diagnosis

UCI neuro-oncologist uses comprehensive approach to battle brain cancer

UCI neuro-oncologist uses comprehensive approach to battle brain cancer

Finding new clues to combat glioblastoma

Finding new clues to combat glioblastoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.